Pioneering concussion
assessment since 2017

Our present focus lies in scientific and clinical research into the NUROCHEK system and its application in the assessment of brain function.

“Headsafe is all about changing the accepted way we analyse brain function with our world leading Nurochek system. Being part of the team that has created this technology is something special.”

Leadership Team

30 years in sports, head and neck injuries. Acclaimed MedTech leader and concussion advocate.

Dr. Adrian Cohen

Founder and CEO

Experienced corporate CFO (VW) and early- stage CEO, serial tech entrepreneur.

Dr. Kay Trippner


Biomedical Engineer and Neuroscientist with strong background in concussion research, quality systems and regulatory processes.

Dylan Mahony

CTO/Head of Research

Corporate and early- stage management experience. Medtech Project Manager (ResMed).

Aaron Downing

Product Development

Nurochek: Built by experts in medicine, sport and healthcare

Australia’s annual Good Design Awards program is one of the oldest and most prestigious international design awards in the world, promoting excellence in design and innovation since 1958.

Our NUROCHEK system received the 2020 Good Design Award of the Year from Good Design Australia. The highest award given, selected from 30 Best in Class category award winners, recognises the NUROCHEK system for outstanding design and innovation.

Industry-leading US advisors

Lorem ipsum dolor sit amet, con

Concussion KOL

Strategic Advisor and architect of Headsafe’s US go to market plan. Previous CEO of market leader in concussion testing – successful exit 2021.

Lorem ipsum dolor sit ametLorem ipsum dolor sit amet, con


Mike Wahlster

Strategic Advisor US marketing

Lorem ipsum dolor sit amet, consectetur adipiscing eli

Sporting KOL

Former NFL Player and now player’s Agent. Deep connections to the NFL, NFL Players Association, team owners and doctors.

Lorem ipsum dolor sit amet, consectetur adipiscing eliLorem ipsum dolor sit amet, consectetur adipiscing eli

Kennard McGuire

Business and Strategic Advisor

ctetur adipis

Regulatory KOL

Previous FDA position in Neurology/Devices. PhD in Neuroscience.

quas esed moloriam inis eos etur. Et accaernatae por moloriam inis eos etur. Et accaernatae por modiae sui reicaecabo. Essin ptentecte pa odiae sui reicaecabo. Essin ptentecte pa di sam.

Allison Komiyama

Regulatory Advisor (FDA Neurology/Devices expert)

Experienced Board

Stephen is a seasoned corporate finance executive having had over 35 years of investment banking experience as a Managing Director with JPMorgan Chase and Credit Agricole CIB. In those roles he led many transactions across the debt and equity capital markets, financial advisory, mergers & acquisitions and structured finance areas across a broad range of industry sectors.  Stephen is also an experienced private investor with a focus on early stage investing across the Medtech, Information technology and the consumer products/services areas.

Stephen Brimo

Senior Investment Banking expertise

Founding CEO. Dr Adrian Cohen graduated with honours from the University of NSW in 1983 before residency in orthopaedics and emergency medicine. As concussion became recognised as an important issue in its own right, he created the Headsafe program in 2012. He has been an Adjunct Senior Lecturer at the University of Sydney Faculty of Medicine, supervising undergraduate and postgraduate students in Ophthalmology and Biomedical Engineering.

Dr. Adrian Cohen

Adjunct Senior Lecturer, University of Sydney Faculty of Medicine

Alex McKillop graduated in Electrical Engineering from Sydney University in 1997 and has since worked at the intersection of technology and business in the telecommunications industry for both startups and global network operators before becoming a fulltime Angel Investor. He has personally financed a large number of start-ups in the Medtech, Fintech, Agtech, IT security and Deep Tech sectors and held multiple board positions as well as being an active supporter of the startup ecosystem.

Alex McKillop

Electrical engineer and investor in Medtech, Fintech, Agtech startups

From formal incorporation in 2017, significant progress has been made.


Feb 2017

HeadsafeIP Incorporated

Apr 2017

Clinical Advisory Panel appointed

May 2017

Slingshot HCF Catalyst Accelerator program

Jul 2017

Global Bridging Grant, Jobs4NSW MVP Grant

Aug 2017

Board constituted


Jan 2018

ISO13485 prototype

April 2018

Jobs4NSW Building Partnerships Grant

May 2018

Research prototype

Nov 2018

$175,000 in Australian Government funding


Feb 2019

Accepted to TMCx (Texas Medical Center Accelerator)

Mar 2019

Initial FDA Clearance


Dec 2021

Second FDA submission


Dec 2023

FDA clearance as Aid to Diagnosis

Our values and beliefs



Committed to becoming the gold standard in concussion assessment via Nurochek, and is a key technology in the routine assessment of a variety of brain injuries and illnesses.



Eliminating preventable brain injury through simple and objective diagnostic technology, creating lasting value.



We are a collaborative, goal driven team who aim to achieve optimal outcomes. Transparency and inclusivity makes for a highly satisfying workplace.

Saving brains creates lasting value.

Discover how we’re leading the charge in concussion assessment.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.